About Magdale Pharma Private Limited
Data last updated:
Magdale Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 12 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PTC220893. Its GSTIN is 27AAHCM3710F1ZQ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Francis Fonseca and Christine Helen Fonseca.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹59.06 Lakh, a decline of 83% compared to the previous year. For the same year it recorded a net loss of ₹2.85 Lakh (net margin -4.8%) and EBITDA of -₹2.27 Lakh (EBITDA margin -3.8%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 36% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website magdalepharma.com.
Company details
Contact details
Magdale Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is magdalepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1201 Cts No 38 Sharon Rose Chsl, Village Valnai Tank Road Malad West, Mumbai, Maharashtra, India – 400064
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Magdale Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magdale Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Magdale Pharma Private Limited, buy the company report.
Financials of Magdale Pharma Private Limited
FY 2025 filings availableMagdale Pharma Private Limited reported revenue of ₹59.06 Lakh (down 83% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years, including a 83% fall in the latest year. EBITDA fell 161% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.8% | ||||
| Net Profit Margin | -4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Magdale Pharma Private Limited, buy the company report.
Board of directors of Magdale Pharma Private Limited
Magdale Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Francis Fonseca Also directs: Richygold International Private Limited | Director | 27 Jan 2022 | 4 Years 9 Months | Current |
| Christine Helen Fonseca | Director | 29 Jul 2015 | 11 Years 2 Months | Current |
Peer comparison
Magdale Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Scortis Pharma Limited | ₹59.59 Lakh (FY 2025) | -8.0% | Rajasthan, India | |||
| Polychem Formulations Private Limited | ₹59.55 Lakh (FY 2025) | 930.0% | Kanalpirivu, Kerala, India | |||
| Magdale Pharma Private Limitedthis company | ₹59.06 Lakh (FY 2024) | -₹2.85 Lakh | -4.8% | -83.0% | Mumbai, Maharashtra, India | |
| Archem Drugs Private Limited | ₹58.83 Lakh (FY 2025) | 3.0% | Patna, Bihar, India |
To see the full peer comparison of Magdale Pharma Private Limited, buy the company report.
Auditor
Magdale Pharma Private Limited is audited by BHARAT B SHAH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARAT B SHAH & CO. | FY 2017 | 101201W |
Shareholding
The shareholding of Magdale Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Magdale Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Magdale Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magdale Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Magdale Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM3710F1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Magdale Pharma Private Limited, buy the company report.
Recent activity
Magdale Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Vinay Adrian Fonseca ceased to be Director on 07 Mar 2022.
Frequently asked questions
Magdale Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 12 August 2011 (15+ years old) and is registered under CIN U24100MH2011PTC220893.
Magdale Pharma has 2 current directors:
- Francis Fonseca - Director
- Christine Helen Fonseca - Director
The latest financial statements of Magdale Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Magdale Pharma is 27AAHCM3710F1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Magdale Pharma is U24100MH2011PTC220893. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magdale Pharma was incorporated on 12 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Magdale Pharma by revenue are Scortis Pharma Limited, Polychem Formulations Private Limited, Archem Drugs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vinay Adrian Fonseca ceased to be Director on 07 Mar 2022. Francis Fonseca was appointed as Director on 27 Jan 2022. Francis Fonseca ceased to be Director on 25 Mar 2017. Magdale Pharma has 4 board changes on record in total.
Magdale Pharma can be reached through the website magdalepharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Magdale Pharma is at 1201 Cts No 38 Sharon Rose Chsl, Village Valnai Tank Road Malad West, Mumbai, Maharashtra, India – 400064.
Magdale Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.